IP Library Granted Patent US 12,257,413
Granted Patent B2
US 12,257,413 · App. 17/051,579 · Granted Mar 25, 2025

Implantable access device for accessing the vascular system of a human or animal body, particularly subcutaneously implantable access port

Inventor: Stanislas Marie Bertrand Achard de la Vente (Canton de Neuchâtel, CH)
Assignee: PFM MEDICAL GMBH
A61M39/0208A61M2210/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,257,413
App. No.
17/051,579
Granted
Mar 25, 2025
Kind
B2
Abstract

An implantable access device for accessing the vascular system of a human or animal body, particularly subcutaneously implantable access port, comprising: a port body with at least one outlet opening connected or connectable to a catheter for accessing the vascular system of the human or animal body; a needle entrance with at least one inlet opening for receiving a needle, wherein the needle entrance is connected to the port body and movable relative to the port body between a first, unactuated operating condition and a second, actuated operating condition; and a flexible socket arranged between the port body and the needle entrance and at least covering the area where the needle entrance moves relative to the port body to prevent tissue growth in this area.

Claims (28)

1. An implantable access device to access a vascular system of a human or animal body, particularly a subcutaneously implantable access port, comprising:

a port body with at least one outlet opening connected or connectable to a catheter to access the vascular system of the human or animal body;

a needle entrance with at least one inlet opening to receive a needle, wherein the needle entrance is connected to the port body and pivotably movable relative to the port body between a first, unactuated operating condition and a second, actuated operating condition; and

a flexible socket forming an external portion of the port, wherein the flexible socket is arranged between the port body and the needle entrance and at least covers an area or volume where the needle entrance moves relative to the port body to prevent tissue growth in the area or volume where the needle entrance moves relative to the port body,

wherein the flexible socket at least covers the area or volume where the needle entrance moves relative to the port body without covering the at least one inlet opening to receive the needle, and

wherein, during movement of the needle entrance relative to the port body between the first, unactuated operating condition and the second, actuated operating condition, the flexible socket is deformed by the movement of the needle entrance relative to the port body to push tissue away from the implantable access device.

2. The implantable access device according to claim 1 , wherein the flexible socket is hollow.

3. The implantable access device according to claim 1 , wherein the flexible socket has a first opening to connect the flexible socket to the port body and a second opening to connect the flexible socket to the needle entrance.

4. The implantable access device according to claim 3 , wherein the flexible socket is hollow.

5. The implantable access device according to claim 3 , wherein the first opening of the flexible socket is smaller than a connecting portion of the port body, where the first opening of the flexible socket is connected to the port body.

6. The implantable access device according to claim 5 , wherein the first opening of the flexible socket and the connecting portion of the port body have corresponding surfaces.

7. The implantable access device according to claim 6 , wherein the corresponding surfaces comprise at least one protrusion and at least one recess, wherein the at least one protrusion is disposed in the at least one recess.

8. The implantable access device according to claim 7 , wherein the at least one protrusion disposed in the at least one recess forms a barbed connection.

9. The implantable access device according to claim 1 , wherein at least a part of the flexible socket is connected to the port body by clamping between two corresponding parts of the port body.

10. An implantable access device to access a vascular system of a human or animal body, particularly a subcutaneously implantable access port, comprising:

a port body with at least one outlet opening connected or connectable to a catheter to access the vascular system of the human or animal body;

a needle entrance with at least one inlet opening to receive a needle, wherein the needle entrance is connected to the port body and movable relative to the port body between a first, unactuated operating condition and a second, actuated operating condition;

a receptacle movably connected to the port body, wherein the needle entrance is connectable to the receptacle such that the receptacle and the needle entrance are movable relative to the port body; and

a flexible socket forming an external portion of the port, wherein the flexible socket is arranged between the port body and the needle entrance and at least covers an area or volume where the needle entrance moves relative to the port body without covering the at least one inlet opening to receive the needle,

wherein the flexible socket prevents tissue growth in the area or volume where the needle entrance moves relative to the port body, and

wherein, during movement of the needle entrance relative to the port body between the first, unactuated operating condition and the second, actuated operating condition, the flexible socket is deformed by the movement of the needle entrance relative to the port body to push tissue away from the implantable access device.

11. The implantable access device according to claim 10 , wherein at least a part of the flexible socket is clamped between corresponding surfaces of the receptacle and the needle entrance.

12. The implantable access device according to claim 11 , wherein the flexible socket has a first opening to connect the flexible socket to the port body and a second opening to connect the flexible socket to the needle entrance, and

wherein the second opening of the flexible socket is clamped between the corresponding surfaces of the receptacle and the needle entrance.

13. The implantable access device according to claim 1 , wherein the flexible socket comprises rubber.

14. The implantable access device according to claim 1 , wherein the flexible socket comprises silicone.

15. The implantable access device according to claim 1 , wherein the needle entrance is translationally movable relative to the port body.

16. The implantable access device according to claim 1 , wherein the first, unactuated operating condition and the second, actuated operating conditions are each a stable operating condition of a bistable mechanism.

Assignments (2)
CHANGE OF NAME Recorded Oct 31, 2024
From: PFM MEDICAL AG
To: PFM MEDICAL GMBH
Reel/Frame 069282/0994 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 29, 2020
From: ACHARD DE LA VENTE, STANISLAS MARIE BERTRAND
To: PFM MEDICAL AG
Reel/Frame 054212/0306 →
Priority Claims (1)
EP 18169998 · Apr 29, 2018 · regional
Continuity (1)
Related Publication 20210085946A1 · Mar 25, 2021
References Cited (42)
US 3196839A · Bertoglio et al. · 1965 [cited by applicant]
US 4861341A · Woodburn · 1989 [cited by applicant]
US 5098398A · Lundgren · 1992 [cited by applicant]
US 5350360A · Ensminger et al. · 1994 [cited by applicant]
US 5352204A · Ensminger · 1994 [cited by applicant]
US 5356381A · Ensminger et al. · 1994 [cited by applicant]
US 5741228A · Lambrecht · 1998 [cited by examiner]
US 5848989A · Villani · 1998 [cited by examiner]
US 5911706A · Estabrook et al. · 1999 [cited by applicant]
US 6007516A · Burbank et al. · 1999 [cited by applicant]
US 6056717A · Finch et al. · 2000 [cited by applicant]
US 6120492A · Finch et al. · 2000 [cited by applicant]
US 6190352B1 · Haarala et al. · 2001 [cited by applicant]
US 6193684B1 · Burbank et al. · 2001 [cited by applicant]
US 6454170B1 · Feeser · 2002 [cited by applicant]
US 6506182B2 · Estabrook et al. · 2003 [cited by applicant]
US 6565525B1 · Burbank et al. · 2003 [cited by applicant]
US 7056316B1 · Burbank et al. · 2006 [cited by applicant]
US 10307581B2 · Hibdon · 2019 [cited by examiner]
US 10746035B2 · Frey · 2020 [cited by examiner]
US 20050131325A1 · Chen et al. · 2005 [cited by applicant]
US 20050203484A1 · Nowak · 2005 [cited by applicant]
US 20070016162A1 · Burbank et al. · 2007 [cited by applicant]
US 20090221974A1 · Paganon · 2009 [cited by applicant]
US 20090306606A1 · Lancette · 2009 [cited by examiner]
US 20100274223A1 · Teitelbaum et al. · 2010 [cited by applicant]
US 20100286615A1 · Gyrn et al. · 2010 [cited by applicant]
US 20190232035A1 · Fedor · 2019 [cited by examiner]
DE 809514 · 1951 [cited by applicant]
DE 812404 · 1951 [cited by applicant]
DE 1267570 · 1968 [cited by applicant]
DE 19624320 · 1997 [cited by applicant]
EP 0332943 · 1989 [cited by applicant]
EP 1016431 · 2000 [cited by applicant]
EP 1629862 · 2006 [cited by applicant]
EP 1765456 · 2011 [cited by applicant]
GB 2192338 · 1988 [cited by applicant]
JP 2009515626A · 2009 [cited by applicant]
WO 9855167 · 1998 [cited by applicant]
International Search Report from corresponding PCT Appln. No. PCT/EP2019/060118, dated Jul. 10, 2019. [cited by applicant]
Written Opinion from corresponding PCT Appln. No. PCT/EP2019/060118, dated Jul. 10, 2019. [cited by applicant]
Notification of Reasons for Rejection of Japanese Application No. 2021-508067, Drafted Dec. 6, 2022, Forwarded Dec. 13, 2022, 4 pages including English translation. [cited by applicant]